These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

629 related items for PubMed ID: 9106012

  • 1. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
    Barry AL, Fuchs PC.
    J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
    [Abstract] [Full Text] [Related]

  • 2. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS, Mazens-Sullivan MF, Bartlett RC.
    Chemotherapy; 1992 Feb; 38(5):308-18. PubMed ID: 1337507
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.
    Barry AL, Fuchs PC.
    Antimicrob Agents Chemother; 1991 May; 35(5):955-60. PubMed ID: 1906696
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the mechanism of action and resistance of two new fluoroquinolones, rufloxacin and MF961 with those of ofloxacin and fleroxacin in gram-negative and gram-positive bacteria.
    Piddock LJ, Panchal S, Norte V.
    J Antimicrob Chemother; 1993 Jun; 31(6):855-63. PubMed ID: 8395493
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci.
    Rotstein C, Amsterdam D, Beam TR, Mandell LA, Gorzynski EA.
    Diagn Microbiol Infect Dis; 1993 Jul; 17(1):85-91. PubMed ID: 8395375
    [Abstract] [Full Text] [Related]

  • 9. Dissociated resistance among fluoroquinolones.
    Thomson KS, Sanders CC.
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2095-100. PubMed ID: 7811025
    [Abstract] [Full Text] [Related]

  • 10. The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolones.
    Thomson KS, Sanders CC.
    J Antimicrob Chemother; 1998 Aug; 42(2):179-87. PubMed ID: 9738835
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones.
    Sader HS, Erwin ME, Jones RN.
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):372-81. PubMed ID: 1327789
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of grepafloxacin (OPC-17116) against anaerobic bacteria.
    Wexler HM, Molitoris E, Finegold SM.
    Diagn Microbiol Infect Dis; 1994 Jun; 19(2):129-33. PubMed ID: 7805357
    [Abstract] [Full Text] [Related]

  • 13. Comparative in vitro activity of fleroxacin, two other quinolones and three board-spectrum beta-lactams using the E-Test.
    Sobottka I, Neumann S, Laufs R.
    Chemotherapy; 1994 Jun; 40(5):293-8. PubMed ID: 7956451
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628.
    Barrett MS, Jones RN, Erwin ME, Johnson DM, Briggs BM.
    Diagn Microbiol Infect Dis; 1991 Jun; 14(5):389-401. PubMed ID: 1665774
    [Abstract] [Full Text] [Related]

  • 15. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
    Montanari MP, Prenna M, Mingoia M, Ripa S, Varaldo PE.
    Chemotherapy; 1998 Jun; 44(2):85-93. PubMed ID: 9551237
    [Abstract] [Full Text] [Related]

  • 16. Comparative antimicrobial activity and spectrum of CP-99,219, a novel fluoroquinolone, tested against ciprofloxacin-resistant clinical isolates.
    Murphy SP, Cormican MG, Jones RN.
    Ir J Med Sci; 1995 Jun; 164(4):271-3. PubMed ID: 8522427
    [Abstract] [Full Text] [Related]

  • 17. [In vitro antibacterial activity of prulifloxacin, a new oral fluoroquinolone].
    Araake M, Hara T, Watabe H, Nishino T.
    Jpn J Antibiot; 2002 Dec; 55(6):778-90. PubMed ID: 12621732
    [Abstract] [Full Text] [Related]

  • 18. Cross-resistance and cross-susceptibility between fluoroquinolone agents.
    Barry AL, Fuchs PC.
    Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1013-8. PubMed ID: 1666360
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone.
    Hosaka M, Yasue T, Fukuda H, Tomizawa H, Aoyama H, Hirai K.
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2108-17. PubMed ID: 1332587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.